Heart and Vascular Clinical Trial - Acurate IDE

ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve through Implantation of ACURATE neo2™ Transfemoral Aortic Valve System in Intermediate or greater Surgical Risk Subjects  

Drug

Device: ACURATE neo2 Aortic Transfemoral Valve System

Trial Type

Interventional

Age Range

18 years or older

Condition

Cardiovascular Heart and vascular Aortic Stenosis

Keywords

Boston Scientific | Transcatheter Replacement of Stenotic Aortic Valve | ACURATE neo2™ Transfemoral Aortic Valve System